Existing LifeStance investors to sell 25M shares as company buys back 7M

robot
Abstract generation in progress

LifeStance Health Group (Nasdaq: LFST) announced that certain selling stockholders plan to offer 25,000,000 shares of common stock, with the company not receiving any proceeds from this sale. Concurrently, LifeStance has authorized the repurchase of 7,000,000 shares from the underwriter, J.P. Morgan, at the same price as the offering, provided the offering completes. Historically, similar secondary offerings have led to significant stock price drops, though the current reaction has been milder.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)